Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.2880
+0.0026 (0.91%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $921.84 thousand as of August 10, 2026. Its market cap has decreased by -73.11% in one year.
Market Cap
921.84K
Enterprise Value
10.74M
1-Year Change
-73.11%
Ranking
Category
Stock Price
$0.29
ChartMarket Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $921.84K, a decrease of -98.08%. That is a compound annual growth rate of -56.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 921.84K | -74.83% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.20% |
| Dec 29, 2023 | 2.64M | -57.38% |
| Dec 30, 2022 | 6.19M | -83.57% |
| Dec 31, 2021 | 37.69M | -21.62% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CDT Equity | 2.16M |
| Decoy Therapeutics | 2.09M |
| Genprex | 2.05M |
| Calidi Biotherapeutics | 1.97M |
| Matinas BioPharma Holdings | 1.81M |
| Bone Biologics | 1.67M |
| VivoSim Labs | 1.64M |
| Biodexa Pharmaceuticals | 1.58M |